Log in

FSD Pharma Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: $5.36
52-Week Range N/A
Volume4,870 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
FSD Pharma Inc. operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc., holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products developed by SciCann Therapeutics Inc. The company was formerly known as Century Financial Capital Group Inc. and changed its name to FSD Pharma Inc. in May 2018. FSD Pharma Inc. was incorporated in 1994 and is headquartered in Cobourg, Canada.
Read More
FSD Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.74 out of 5 stars

Industry, Sector and Symbol

Industry Software - Application



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive HUGE News and Ratings via Email

Sign-up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

FSD Pharma (CNSX:HUGE) Frequently Asked Questions

Who are some of FSD Pharma's key competitors?

What other stocks do shareholders of FSD Pharma own?

What is FSD Pharma's stock symbol?

FSD Pharma trades on the CNSX under the ticker symbol "HUGE."

How do I buy shares of FSD Pharma?

Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.